News

RSS feed

Industrie Pharma

Gene therapy: encouraging phase I results for the gamma sarcoglycanopathy

Industrie Pharma

Fulvio Mavilio, Scientific Director

La revue du Praticien

Genethon: laboratory of theTelethon

(Reporter: Catherine Holué)

La Recherche

Gene therapy on an industrial scale

Genethon Lecture Series: 2012, February 15th

 Wednesday February 15th, 2012: « Oligonucleotides, Endonucleases and Microdystrophins for genetic therapy of the muscular dystrophies » Professor George Dickson (Chair of Molecular Cell Biology, School of Biological Sciences, Royal Holloway, University of London, UK)

Nature

French institute prepares for gene-therapy push.

Genethon relaunches itself as a force for translational medicine.

Biotech finances

Fulvio Mavilio, new CSO of Genethon

Le Quotidien du Médecin

Gamma-sarcoglycanopathy: Conclusive gene therapy trial

(Dr Emmanuel de Viel – n° 9067 – mardi 17 janvier 2012)

L’Humanité Dimanche

Trillions of viruses to treat rare diseases

Biotechs Actualités pharma

Biotech essential: Bioproduction